Back to FRED ALGER MANAGEMENT, LLC FRED ALGER MANAGEMENT, LLC

AXSMAXSM
14 quarters

Position history for FRED ALGER MANAGEMENT, LLCFRED ALGER MANAGEMENT, LLC's holdings in AXSOME THERAPEUTICS INC.

No. Fred Alger Management exited its AXSM (Axsome Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 7,373 shares worth $859,913. Fred Alger Management first reported AXSM in Q2 2019 and held it in 10 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$515,000

Total Shares Change

-20,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$104.39
0
2025-Q1
New
7,373
-
$859,9130.0%$116.63
34
2024-Q4
Exited
0
-100.0%
$00.0%$84.61
0
2024-Q3
New
9,466
-
$850,7090.0%$89.87
34
2023-Q3
Exited
0
-100.0%
$00.0%$69.89
0
2023-Q2
New
17,422
-
$1.3M0.0%$71.86
35
2021-Q1
Exited
0
-100.0%
$00.0%$56.62
0
2020-Q4
Decreased
14,670
-2.2%
$1.2M0.0%$81.47
0
2020-Q3
Decreased
15,001
-34.8%
$1.1M0.0%$71.25
0
2020-Q2
Increased
23,000
+21.1%
$1.9M0.0%$82.28
31
2020-Q1
Increased
19,000
+18.8%
$1.1M0.0%$58.83
30
2019-Q4
Increased
16,000
+6.7%
$1.7M0.0%$103.36
27
2019-Q3
Decreased
15,000
-25.0%
$304,0000.0%$20.24
0
2019-Q2
New
20,000
-
$515,0000.0%$25.75
33

Other major holders of AXSM: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used